A brain aneurysm is a weak, bulging spot on the wall of an artery. Our unique portfolio for ruptured and unruptured aneurysms is backed by numerous clinical studies and independent research for great performance and versatility.
Find out more
A stroke is a permanent injury to the brain caused by blockage of blood flow depriving the brain tissue of oxygen and nutrients. This diverse portfolio includes carotid stents, aspiration catheters, and mechanical thrombectomy products.
Find out more
Malformations are an abnormal tangle of blood vessels that cause arteries to shunt directly into veins, the blood flow never slows down enough to provide oxygen and nutrients. We took a novel approach by designing a ready-to-use liquid embolic device for malformations.
Find out more
MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, prospective EU observational study called STRAIT, to evaluate the Safety and Performance of the BOBBY Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke.
MicroVention, Inc., a subsidiary of Terumo and a global neurovascular company, announced the first U.S. clinical case of its next generation Flow Diverter, the FRED X device, at Thomas Jefferson University Hospital located in Philadelphia.
The WEB™ Aneurysm Embolization System expands with a lower profile delivery system and new size configurations.
MicroVention, Inc., a U.S. based subsidiary of Terumo and leading global neurovascular company, announced today the filing of a second lawsuit against Balt USA, LLC and four former employees for trade secret misappropriation.
